Sickle cell disease (SCD) is recognized as a significant health disparity in the United States due to the number of patients affected, the paucity of available providers, disease stigmatization, and a lack of treatment options for affected individuals (4). In certain regions of the US, these issues are further worsened by a large percentage of affected patients living in rural regions with limited access to care, lower socioeconomic status, and fewer funding options (5, 6). South Carolina (SC) is a prime example of state that is tremendously under-resourced to treat individuals living with SCD. State-level engagement of pediatric hematologists, managed care organizations, patients, and community foundations resulted in formation of the South Carolina-Sickle Cell (SC2) statewide network designed to increase access to evidence-based care for all individuals living with SCD and to improve their clinical outcomes through access to a SCD medical home (Spoke) connected to a regional specialty care center (Hub). This approach harnesses the state?s resources to improve care for individuals with SCD, utilize the strengths of partnering hospital systems, and use a technology based approach to extend care to rural areas. This project, iSCENSC (Implementation of a Sickle Cell Enhanced Novel Care Network in South Carolina) is designed to evaluate intervention effectiveness for achieving full implementation of the SC2 network and to determine if the hub and spokes model of care increases access to quality care for individuals with SCD and produces findings sufficient to identify replicable methods for optimal care enrichment especially in rural populations.
Specific Aims are: 1. Perform a systematic needs assessment in three target regions currently involved in SC2 (Midlands, Pee Dee and Lowcountry) to assess the gap between current and SCD best practices for adolescent and adult SCD patients and to identify care delivery issues associated with disease-specific care primary care, acute care management, and care coordination. 2: Engage all relevant stakeholders (patients/caregivers, providers, SC2 partners) to begin building capacity for the conduct and assessment of targeted interventions to increase implementation readiness within three SC regions and partnering health systems and to further inform Phase II implementation strategies. 3: Initiate comparative effectiveness study using an interrupted time series, multi-sector, multi-modal design including specific implementation intervention strategies. iSCENSC will be the first multilevel, multicenter implementation science study in adolescents and adults with SCD aiming to achieve the outcome of a statewide SCD network. We propose the first large study of barriers inhibiting adoption and use of NHLBI SCD Guideline and of effectiveness of dissemination and implementation strategies in closing existing guideline-to-practice gaps and reducing longstanding disparities in SCD treatment, policy, and funding support of SCD care delivery.

Public Health Relevance

Sickle cell disease (SCD) is a significant health disparity in the United States because a lot of individuals are affected by it, there are few healthcare providers to offer people adequate services to people with SCD, and treatment options are limited, especially for children with SCD as they move into adulthood. The goal of iSCENSC is to find out how we can best make changes in healthcare systems, our communities, and in our policies in support of SC2 (Sickle Cell-South Carolina) a statewide network in South Carolina (SC) designed to have more people receive care that works for SCD throughout their lifetime and to decrease their chances of being sick or dying too early as a result of having SCD. This project will evaluate educational, training, telemedicine, and enhanced treatment options to improve the system of care for people living with SCD in South Carolina.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01HL133990-02
Application #
9327045
Study Section
Special Emphasis Panel (ZHL1)
Program Officer
Smith, Sharon M
Project Start
2016-08-05
Project End
2022-06-30
Budget Start
2017-07-01
Budget End
2018-06-30
Support Year
2
Fiscal Year
2017
Total Cost
Indirect Cost
Name
Medical University of South Carolina
Department
Public Health & Prev Medicine
Type
Schools of Medicine
DUNS #
183710748
City
Charleston
State
SC
Country
United States
Zip Code
29403
Baumann, Ana A; Belle, Steven H; James, Aimee et al. (2018) Specifying sickle cell disease interventions: a study protocol of the Sickle Cell Disease Implementation Consortium (SCDIC). BMC Health Serv Res 18:500